Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 71 | 2 | 77 | +8 |
| Shares | 3.94M | 366.7K | 3.60M | +29.9K (+0.8%) |
| Value | $25.5M | $2.38M | $43.2M | +$20.0M (+86.5%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lindbrook Capital, LLC | 383,351 | $4.61M | 0.57% |
| XTX Topco Ltd | 57,083 | $686.7K | 0.15% |
| Russell Investments Group, Ltd. | 56,516 | $679.9K | 0.00% |
| Gsa Capital Partners LLP | 46,039 | $554.0K | 0.07% |
| Belpointe Asset Management LLC | 29,900 | $359.7K | 0.02% |
| Landscape Capital Management, L.L.C. | 26,220 | $315.4K | 0.05% |
| 683 Capital Management, LLC | 20,537 | $247.1K | 0.02% |
| Balyasny Asset Management LLC | 17,341 | $208.6K | 0.00% |
| Lighthouse Investment Partners, LLC | 17,227 | $207.2K | 0.04% |
| Calamos Advisors LLC | 14,746 | $177.4K | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $152.9K | 0.01% |
| Janney Montgomery Scott LLC | 12,379 | $149.0K | 0.00% |
| Vontobel Holding Ltd. | 12,000 | $144.4K | 0.00% |
| Mirabella Financial Services LLP | 11,974 | $144.0K | 0.01% |
| Draper Asset Management, LLC | 9,974 | $120.0K | 0.17% |
| Glass Jacobson Investment Advisors llc | 9,350 | $112.5K | 0.06% |
| Advisory Services Network, LLC | 500 | $6.01K | 0.00% |
| Corrado Advisors, LLC | 450 | $5.41K | 0.00% |
| Beacon Capital Management, LLC | 219 | $2.63K | 0.00% |
| Private Advisor Group, LLC | 11,794 | $142 | 0.00% |
Sold out (12)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Two Sigma Investments, LP | 163,015 | $1.06M |
| ETF Managers Group, LLC | 94,493 | $612.0K |
| Walleye Capital LLC | 78,418 | $508.0K |
| Ameriprise Financial Inc | 39,525 | $256.0K |
| Jump Financial, LLC | 36,100 | $234.0K |
| Commonwealth Equity Services, LLC | 30,014 | $194.0K |
| Ergoteles LLC | 24,149 | $156.0K |
| Virtu Financial LLC | 21,526 | $139.0K |
| Knoll Capital Management, LLC | 20,000 | $130.0K |
| Banque Cantonale Vaudoise | 20,000 | $130.0K |
| Schonfeld Strategic Advisors LLC | 16,400 | $106.0K |
| Raymond James Financial Services Advisors, Inc. | 10,372 | $67.0K |
Not filed for Q4 2022 yet (2)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Morgan Jess S & Co Inc | 366,401 | $2.37M |
| Covington Capital Management | 325 | $2.00K |